
In France, people with intellectual disability (ID) account approximately for 2.5 % of the total population. Life expectancy of ID increased over the last years, and this raised the risk of cancers developing in this group of patients. Overall, the prevalence of cancers for those patients is much like that of the general population, but they have specificities regarding their epidemiology, diagnostic and treatment. The type of cancers occurring differs depending on the age and the etiology of the ID of the patient. ID may raise special difficulties for the management and the treatment of the cancer that may be, ultimately, non optimal.